191 related articles for article (PubMed ID: 31659850)
1. Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial.
Campbell HE; Gray AM; Watson J; Jackson C; Moseley C; Cruickshank ME; Kitchener HC; Rivero-Arias O
Health Expect; 2020 Feb; 23(1):202-211. PubMed ID: 31659850
[TBL] [Abstract][Full Text] [Related]
2. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
[TBL] [Abstract][Full Text] [Related]
3. Exploring women's preferences for birth settings in England: A discrete choice experiment.
Fletcher BR; Rowe R; Hollowell J; Scanlon M; Hinton L; Rivero-Arias O
PLoS One; 2019; 14(4):e0215098. PubMed ID: 30973919
[TBL] [Abstract][Full Text] [Related]
4. Preferences for cervical cancer screening service attributes in rural China: a discrete choice experiment.
Li S; Liu S; Ratcliffe J; Gray A; Chen G
Patient Prefer Adherence; 2019; 13():881-889. PubMed ID: 31239646
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Tsiachristas A; Gittins M; Kitchener H; Gray A
J Med Screen; 2018 Jun; 25(2):99-109. PubMed ID: 28530515
[TBL] [Abstract][Full Text] [Related]
6. A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial.
Kitchener H; Gittins M; Cruickshank M; Moseley C; Fletcher S; Albrow R; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
J Med Screen; 2018 Jun; 25(2):88-98. PubMed ID: 28530513
[TBL] [Abstract][Full Text] [Related]
7. Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment.
Miners A; Nadarzynski T; Witzel C; Phillips AN; Cambiano V; Rodger AJ; Llewellyn CD
PLoS Med; 2019 Apr; 16(4):e1002779. PubMed ID: 30973868
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
[TBL] [Abstract][Full Text] [Related]
9. Development and field testing of a tool to elicit women's preferences among cervical cancer screening modalities.
Wood B; Taljaard M; El-Khatib Z; McFaul S; Graham ID; Little J
J Eval Clin Pract; 2019 Dec; 25(6):1169-1181. PubMed ID: 31423705
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
[TBL] [Abstract][Full Text] [Related]
11. Exploring women's preferences for HPV-based cervical cancer screening in South Africa.
Oberlin AM; Pasipamire T; Chibwesha CJ
Int J Gynaecol Obstet; 2019 Aug; 146(2):192-199. PubMed ID: 31127861
[TBL] [Abstract][Full Text] [Related]
12. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
Vass CM; Rigby D; Payne K
Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
[TBL] [Abstract][Full Text] [Related]
14. Women's preferences for cervical cancer screening: a study using a discrete choice experiment.
Wordsworth S; Ryan M; Skåtun D; Waugh N
Int J Technol Assess Health Care; 2006; 22(3):344-50. PubMed ID: 16984063
[TBL] [Abstract][Full Text] [Related]
15. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
[TBL] [Abstract][Full Text] [Related]
16. Young people's preferences for the use of emerging technologies for asymptomatic regular chlamydia testing and management: a discrete choice experiment in England.
Eaton S; Biggerstaff D; Petrou S; Osipenko L; Gibbs J; Estcourt CS; Sadiq T; Szczepura A
BMJ Open; 2019 Jan; 9(1):e023663. PubMed ID: 30700477
[TBL] [Abstract][Full Text] [Related]
17. What are GPs' preferences for financial and non-financial incentives in cancer screening? Evidence for breast, cervical, and colorectal cancers.
Sicsic J; Krucien N; Franc C
Soc Sci Med; 2016 Oct; 167():116-27. PubMed ID: 27619755
[TBL] [Abstract][Full Text] [Related]
18. HPV sampling options for cervical cancer screening: preferences of urban-dwelling Canadians in a changing paradigm.
Datta GD; Mayrand MH; Qureshi S; Ferre N; Gauvin L
Curr Oncol; 2020 Apr; 27(2):e171-e181. PubMed ID: 32489266
[TBL] [Abstract][Full Text] [Related]
19. Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990-2013.
Mansfield C; Tangka FK; Ekwueme DU; Smith JL; Guy GP; Li C; Hauber AB
Prev Chronic Dis; 2016 Feb; 13():E27. PubMed ID: 26916898
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
